Clinical Trials Browser

Phase 1 × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × Inotuzumab Ozogamicin × Clear all

NCT03991884 2023-07-06

Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

Phase 1 Completed

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma